-
Enterococcus faecium is a Gram-positive, gamma-hemolytic or non-hemolytic
bacterium in the
genus Enterococcus. It can be
commensal (innocuous, coexisting...
-
commensal organisms in the
intestines of humans: E.
faecalis (90–95%) and E.
faecium (5–10%). Rare
clusters of
infections occur with
other species, including...
-
separate mechanism than the
vancomycin resistance seen in VRE
isolates of E.
faecium and E.
faecalis which is
mediated by vanA or vanB. This
species is known...
- susceptible. Quinupristin/dalfopristin can be used to
treat Enterococcus faecium but not E. faecalis. In root-canal treatments,
NaOCl and chlorhexidine...
-
reclassified and
placed in the
genus Enterococcus (including E. faecalis, E.
faecium, E. durans, and E. avium). For example,
Streptococcus faecalis is now Enterococcus...
-
Brachybacterium faecium is a
species of Gram positive,
facultatively anaerobic bacterium.
Colony pigmentation is grey, white, or pale yellow. The cells...
-
virulent and
antibiotic resistant bacterial pathogens including:
Enterococcus faecium,
Staphylococcus aureus,
Klebsiella pneumoniae,
Acinetobacter baumannii...
-
Staphylococcus aureus (MRSA) and with vancomycin-resistant
Enterococcus faecium (VRE), but the
significance of this is
still unknown.
Investigations into...
-
Administration (FDA) are the
treatment of vancomycin-resistant
Enterococcus faecium infections, with or
without bacterial invasion of the bloodstream; nosocomial...
-
against gram-positive
bacteria including Staphylococcus aureus,
Enterococcus faecium and
Clostridioides difficile. It is sold as an anti-diarrhoea and under...
